CHMP5 and Huntington disease: Since the S-specific T cell response may contribute to the vaccine efficacy, at least in terms of control of the clinical manifestation, IFNγ/IL-5 FluoroSpot was performed on splenocytes at 6 months after immunization in the HD groups using pools of peptides covering the entire Wuhan-Spike protein.